12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Actinium, Fred Hutchinson deal

The center granted Actinium worldwide rights to develop and commercialize BC8. The mAb against CD45 is in...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >